Symbols / BSX Stock $64.87 +8.99% Boston Scientific Corporation

Healthcare • Medical Devices • United States • NYQ
BSX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Stock Fundamentals
Scroll to Statements
Market Cap 96.41B Enterprise Value 106.51B Income 3.56B Sales 20.61B Book/sh 16.34 Cash/sh 1.32
Dividend Yield — Payout 0.00% Employees 59000 IPO — P/E 27.14 Forward P/E 16.97
PEG — P/S 4.68 P/B 3.97 P/C — EV/EBITDA 19.62 EV/Sales 5.17
Quick Ratio — Current Ratio — Debt/Eq 48.92 LT Debt/Eq — EPS (ttm) 2.39 EPS next Y 3.82
EPS Growth 100.00% Revenue Growth 11.60% Earnings 2026-07-22 ROA — ROE — ROIC —
Gross Margin 68.63% Oper. Margin 21.55% Profit Margin 17.29% Shs Outstand 1.49B Shs Float 1.48B Short Float 1.58%
Short Ratio 1.59 Short Interest — 52W High 109.50 52W Low 59.39 Beta 0.78 Avg Volume 17.10M
Volume 40.39M Target Price $95.75 Recom Strong_buy Prev Close $59.52 Price $64.87 Change 8.99%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$95.75
Mean price target
2. Current target
$64.87
Latest analyst target
3. DCF / Fair value
$35.85
Fallback: EPS × 15 (assumed fair P/E). No FCF data; use with …
Ratings
Current target
$64.87
Low
$69.00
High
$112.00
Mean
$95.75

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-23 main Baird Outperform → Outperform $78
2026-04-23 main Goldman Sachs Buy → Buy $84
2026-04-23 main Needham Buy → Buy $77
2026-04-22 main Jefferies Buy → Buy $100
2026-04-22 main Barclays Overweight → Overweight $100
2026-04-22 main BTIG Buy → Buy $80
2026-04-21 main Stifel Buy → Buy $85
2026-04-15 main Truist Securities Buy → Buy $90
2026-04-13 main Mizuho Outperform → Outperform $90
2026-04-07 main Citigroup Buy → Buy $87
2026-04-06 main Evercore ISI Group Outperform → Outperform $80
2026-03-30 reit RBC Capital Outperform → Outperform $115
2026-03-30 down Raymond James Strong Buy → Outperform $88
2026-03-30 reit Needham Buy → Buy $97
2026-03-27 main Goldman Sachs Buy → Buy $93
2026-03-20 main Stifel Buy → Buy $90
2026-03-20 reit Needham Buy → Buy $97
2026-03-18 main Truist Securities Buy → Buy $92
2026-03-17 main UBS Buy → Buy $105
2026-03-11 main Citigroup Buy → Buy $94
News
RSS: Latest BSX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-02 MORANO SUSAN E. Director — 24 $0.00 $0
2026-03-02 WEBER CHRISTOPHE PIERRE Director — 879 $0.00 $0
2026-02-27 WOODWORTH EMILY Officer — 838 — —
2026-02-13 FITZGERALD JOSEPH MICHAEL Officer — 69,796 $0.00 $0
2026-02-13 FITZGERALD JOSEPH MICHAEL Officer — 11,119 — —
2026-02-13 BROWN VANCE R General Counsel — 29,608 $0.00 $0
2026-02-13 BROWN VANCE R General Counsel — 4,808 — —
2026-02-13 WOODWORTH EMILY Officer — 2,711 — —
2026-02-13 O'SULLIVAN MIRIAM Officer — 2,702 — —
2026-02-13 O'CONNOR PADRAIG ANDREW Officer — 2,595 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
20,074.00
+19.87%
16,747.00
+17.61%
14,240.00
+12.29%
12,682.00
Operating Revenue
20,074.00
+19.87%
16,747.00
+17.61%
14,240.00
+12.29%
12,682.00
Cost Of Revenue
6,221.00
+18.34%
5,257.00
+20.99%
4,345.00
+9.83%
3,956.00
Reconciled Cost Of Revenue
5,750.00
+18.70%
4,844.00
+21.80%
3,977.00
+9.77%
3,623.00
Gross Profit
13,853.00
+20.57%
11,490.00
+16.12%
9,895.00
+13.38%
8,727.00
Operating Expense
9,882.00
+16.42%
8,488.00
+13.51%
7,478.00
+11.73%
6,693.00
Research And Development
2,052.00
+27.06%
1,615.00
+14.21%
1,414.00
+6.88%
1,323.00
Selling General And Administration
6,887.00
+15.09%
5,984.00
+15.30%
5,190.00
+14.82%
4,520.00
Other Operating Expenses
46.00
+39.39%
33.00
-28.26%
46.00
-2.13%
47.00
Total Expenses
16,103.00
+17.16%
13,745.00
+16.26%
11,823.00
+11.02%
10,649.00
Operating Income
3,971.00
+32.28%
3,002.00
+24.20%
2,417.00
+18.83%
2,034.00
Total Operating Income As Reported
3,613.00
+38.80%
2,603.00
+11.10%
2,343.00
+42.09%
1,649.00
EBITDA
5,102.00
+32.31%
3,856.00
+11.90%
3,446.00
+25.45%
2,747.00
Normalized EBITDA
5,334.00
+22.68%
4,348.00
+20.11%
3,620.00
+14.38%
3,165.00
Reconciled Depreciation
1,368.00
+7.80%
1,269.00
+6.10%
1,196.00
+5.28%
1,136.00
EBIT
3,734.00
+44.34%
2,587.00
+14.98%
2,250.00
+39.66%
1,611.00
Total Unusual Items
-232.00
+52.85%
-492.00
-182.76%
-174.00
+58.37%
-418.00
Total Unusual Items Excluding Goodwill
-232.00
+52.85%
-492.00
-182.76%
-174.00
+58.37%
-418.00
Special Income Charges
-359.00
+9.57%
-397.00
-436.49%
-74.00
+80.83%
-386.00
Other Special Charges
194.00
—
-111.00
-164.16%
173.00
Impairment Of Capital Assets
46.00
-88.08%
386.00
+565.52%
58.00
-56.06%
132.00
Restructuring And Mergern Acquisition
119.00
+981.82%
11.00
-91.34%
127.00
+115.25%
59.00
Net Income
2,898.00
+56.31%
1,854.00
+16.38%
1,593.00
+128.22%
698.00
Pretax Income
3,385.00
+48.33%
2,282.00
+14.96%
1,985.00
+73.97%
1,141.00
Net Non Operating Interest Income Expense
-320.00
-61.62%
-198.00
+18.52%
-243.00
+47.17%
-460.00
Interest Expense Non Operating
349.00
+14.43%
305.00
+15.09%
265.00
-43.62%
470.00
Net Interest Income
-320.00
-61.62%
-198.00
+18.52%
-243.00
+47.17%
-460.00
Interest Expense
349.00
+14.43%
305.00
+15.09%
265.00
-43.62%
470.00
Interest Income Non Operating
29.00
-72.90%
107.00
+386.36%
22.00
+120.00%
10.00
Interest Income
29.00
-72.90%
107.00
+386.36%
22.00
+120.00%
10.00
Other Income Expense
-267.00
+48.75%
-521.00
-177.13%
-188.00
+56.68%
-434.00
Other Non Operating Income Expenses
-35.00
-20.69%
-29.00
-107.14%
-14.00
+12.50%
-16.00
Gain On Sale Of Security
127.00
+233.68%
-95.00
+5.00%
-100.00
-212.50%
-32.00
Gain On Sale Of Business
—
0.00
0.00
+100.00%
-22.00
Tax Provision
493.00
+13.07%
436.00
+10.94%
393.00
-11.29%
443.00
Tax Rate For Calcs
0.00
-23.56%
0.00
-3.54%
0.00
-49.10%
0.00
Tax Effect Of Unusual Items
-33.87
+63.96%
-93.97
-172.76%
-34.45
+78.81%
-162.60
Net Income Including Noncontrolling Interests
2,892.00
+56.66%
1,846.00
+15.95%
1,592.00
+128.08%
698.00
Net Income From Continuing Operation Net Minority Interest
2,898.00
+56.31%
1,854.00
+16.38%
1,593.00
+128.22%
698.00
Net Income From Continuing And Discontinued Operation
2,898.00
+56.31%
1,854.00
+16.38%
1,593.00
+128.22%
698.00
Net Income Continuous Operations
2,892.00
+56.66%
1,846.00
+15.95%
1,592.00
+128.08%
698.00
Minority Interests
6.00
-25.00%
8.00
+700.00%
1.00
0.00
Normalized Income
3,096.13
+37.48%
2,252.03
+29.98%
1,732.55
+81.72%
953.40
Net Income Common Stockholders
2,898.00
+56.40%
1,853.00
+18.03%
1,570.00
+144.55%
642.00
Diluted EPS
1.94
+55.20%
1.25
+16.82%
1.07
+137.78%
0.45
Basic EPS
1.96
+55.56%
1.26
+16.67%
1.08
+140.00%
0.45
Basic Average Shares
1,480.40
+0.60%
1,471.50
+1.27%
1,453.00
+1.57%
1,430.50
Diluted Average Shares
1,494.50
+0.58%
1,485.90
+1.53%
1,463.50
+1.65%
1,439.70
Diluted NI Availto Com Stockholders
2,898.00
+56.40%
1,853.00
+18.03%
1,570.00
+144.55%
642.00
Amortization
897.00
+4.79%
856.00
+3.38%
828.00
+3.11%
803.00
Amortization Of Intangibles Income Statement
897.00
+4.79%
856.00
+3.38%
828.00
+3.11%
803.00
Depreciation Amortization Depletion Income Statement
897.00
+4.79%
856.00
+3.38%
828.00
+3.11%
803.00
Depreciation And Amortization In Income Statement
897.00
+4.79%
856.00
+3.38%
828.00
+3.11%
803.00
Preferred Stock Dividends
—
—
23.00
-58.18%
55.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
43,673.00
+10.86%
39,395.00
+12.12%
35,136.00
+8.21%
32,469.00
Current Assets
8,794.00
+27.08%
6,920.00
+6.23%
6,514.00
+13.09%
5,760.00
Cash Cash Equivalents And Short Term Investments
1,965.00
+374.64%
414.00
-52.14%
865.00
-6.79%
928.00
Cash And Cash Equivalents
1,965.00
+374.64%
414.00
-52.14%
865.00
-6.79%
928.00
Receivables
2,926.00
+14.39%
2,558.00
+14.81%
2,228.00
+13.10%
1,970.00
Accounts Receivable
2,926.00
+14.39%
2,558.00
+14.81%
2,228.00
+13.10%
1,970.00
Gross Accounts Receivable
3,058.00
+14.66%
2,667.00
+14.07%
2,338.00
+12.46%
2,079.00
Allowance For Doubtful Accounts Receivable
-132.00
-21.10%
-109.00
+0.91%
-110.00
-0.92%
-109.00
Inventory
2,943.00
+4.73%
2,810.00
+13.12%
2,484.00
+33.05%
1,867.00
Raw Materials
849.00
+3.66%
819.00
+5.95%
773.00
+41.06%
548.00
Work In Process
246.00
+27.46%
193.00
+10.92%
174.00
+18.37%
147.00
Finished Goods
1,849.00
+2.84%
1,798.00
+16.98%
1,537.00
+31.26%
1,171.00
Prepaid Assets
299.00
-2.61%
307.00
-2.54%
315.00
+19.32%
264.00
Restricted Cash
—
111.00
-14.62%
130.00
-12.75%
149.00
Assets Held For Sale Current
—
—
—
—
Hedging Assets Current
—
305.00
+91.82%
159.00
-31.47%
232.00
Other Current Assets
661.00
-20.46%
831.00
+149.55%
333.00
-4.86%
350.00
Total Non Current Assets
34,878.00
+7.39%
32,477.00
+13.47%
28,621.00
+7.15%
26,710.00
Net PPE
4,035.00
+22.46%
3,295.00
-0.09%
3,298.00
+16.50%
2,831.00
Gross PPE
7,645.00
+11.97%
6,828.00
+0.68%
6,782.00
+10.94%
6,113.00
Accumulated Depreciation
-3,610.00
-2.18%
-3,533.00
-1.41%
-3,484.00
-6.15%
-3,282.00
Properties
0.00
0.00
0.00
0.00
Land And Improvements
173.00
+20.14%
144.00
+2.86%
140.00
+2.19%
137.00
Buildings And Improvements
2,484.00
+23.03%
2,019.00
+9.55%
1,843.00
+8.73%
1,695.00
Machinery Furniture Equipment
3,827.00
+5.43%
3,630.00
+3.63%
3,503.00
+6.25%
3,297.00
Construction In Progress
1,161.00
+12.17%
1,035.00
+20.77%
857.00
+43.31%
598.00
Other Properties
—
449.00
+2.28%
439.00
+13.73%
386.00
Goodwill And Other Intangible Assets
25,302.00
+6.43%
23,773.00
+16.59%
20,390.00
+8.32%
18,823.00
Goodwill
18,282.00
+6.98%
17,089.00
+18.78%
14,387.00
+11.35%
12,920.00
Other Intangible Assets
7,020.00
+5.03%
6,684.00
+11.34%
6,003.00
+1.69%
5,903.00
Investments And Advances
—
555.00
+34.38%
413.00
+1.47%
407.00
Non Current Deferred Assets
3,675.00
+0.55%
3,655.00
-4.84%
3,841.00
-2.56%
3,942.00
Non Current Deferred Taxes Assets
3,675.00
+0.55%
3,655.00
-4.84%
3,841.00
-2.56%
3,942.00
Other Non Current Assets
1,866.00
+6.39%
1,754.00
+206.64%
572.00
+2.51%
558.00
Total Liabilities Net Minority Interest
19,201.00
+10.40%
17,392.00
+11.44%
15,606.00
+4.77%
14,896.00
Current Liabilities
5,439.00
-15.00%
6,399.00
+29.72%
4,933.00
+29.71%
3,803.00
Payables And Accrued Expenses
4,345.00
+16.39%
3,733.00
+3.64%
3,602.00
+19.11%
3,024.00
Payables
1,144.00
+19.17%
960.00
-17.38%
1,162.00
+6.22%
1,094.00
Accounts Payable
1,144.00
+19.17%
960.00
+1.91%
942.00
+9.28%
862.00
Current Accrued Expenses
3,201.00
+15.43%
2,773.00
+13.65%
2,440.00
+26.42%
1,930.00
Total Tax Payable
—
268.00
+21.82%
220.00
-5.17%
232.00
Current Debt And Capital Lease Obligation
299.00
-83.18%
1,778.00
+234.84%
531.00
+2555.00%
20.00
Current Debt
299.00
-83.18%
1,778.00
+234.84%
531.00
+2555.00%
20.00
Current Deferred Liabilities
313.00
+2.29%
306.00
+15.04%
266.00
+20.91%
220.00
Current Deferred Revenue
313.00
+2.29%
306.00
+15.04%
266.00
+20.91%
220.00
Other Current Liabilities
482.00
-17.18%
582.00
+77.44%
328.00
+6.49%
308.00
Total Non Current Liabilities Net Minority Interest
13,762.00
+25.19%
10,993.00
+3.00%
10,673.00
-3.79%
11,093.00
Long Term Debt And Capital Lease Obligation
11,137.00
+24.19%
8,968.00
+0.08%
8,961.00
-3.25%
9,262.00
Long Term Debt
11,012.00
+24.54%
8,842.00
+3.22%
8,566.00
-3.86%
8,910.00
Long Term Capital Lease Obligation
125.00
-0.79%
126.00
-68.10%
395.00
+12.22%
352.00
Long Term Provisions
—
149.00
-13.37%
172.00
-18.87%
212.00
Tradeand Other Payables Non Current
—
357.00
-24.04%
470.00
-21.27%
597.00
Non Current Deferred Liabilities
220.00
+41.94%
155.00
-65.17%
445.00
+2.77%
433.00
Non Current Deferred Revenue
—
329.00
+5.79%
311.00
+7.61%
289.00
Non Current Deferred Taxes Liabilities
220.00
+41.94%
155.00
+15.67%
134.00
-6.94%
144.00
Other Non Current Liabilities
2,405.00
+28.61%
1,870.00
+199.20%
625.00
+6.11%
589.00
Stockholders Equity
24,232.00
+11.31%
21,770.00
+12.91%
19,281.00
+9.71%
17,574.00
Common Stock Equity
24,232.00
+11.31%
21,770.00
+12.91%
19,281.00
+9.71%
17,574.00
Capital Stock
17.00
+0.00%
17.00
+0.00%
17.00
+0.00%
17.00
Common Stock
17.00
+0.00%
17.00
+0.00%
17.00
+0.00%
17.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
1,746.29
+0.49%
1,737.85
+0.51%
1,729.00
+1.91%
1,696.63
Ordinary Shares Number
1,483.00
+0.57%
1,474.56
+0.60%
1,465.71
+2.26%
1,433.34
Treasury Shares Number
263.29
+0.00%
263.29
+0.00%
263.29
+0.00%
263.29
Additional Paid In Capital
21,505.00
+2.13%
21,056.00
+1.98%
20,647.00
+1.76%
20,289.00
Retained Earnings
5,571.00
+108.42%
2,673.00
+226.37%
819.00
+209.20%
-750.00
Gains Losses Not Affecting Retained Earnings
-610.00
-321.82%
275.00
+461.22%
49.00
-81.78%
269.00
Treasury Stock
2,251.00
+0.00%
2,251.00
+0.00%
2,251.00
+0.00%
2,251.00
Minority Interest
239.00
+2.58%
233.00
-6.05%
248.00
0.00
Other Equity Adjustments
-610.00
-321.82%
275.00
+461.22%
49.00
-81.78%
269.00
Total Equity Gross Minority Interest
24,472.00
+11.22%
22,003.00
+12.66%
19,530.00
+11.14%
17,573.00
Total Capitalization
35,244.00
+15.13%
30,612.00
+9.93%
27,847.00
+5.15%
26,484.00
Working Capital
3,355.00
+543.95%
521.00
-67.05%
1,581.00
-19.21%
1,957.00
Invested Capital
35,543.00
+9.73%
32,390.00
+14.14%
28,378.00
+7.07%
26,504.00
Total Debt
11,436.00
+6.42%
10,746.00
+13.21%
9,492.00
+2.26%
9,282.00
Net Debt
9,346.00
-8.43%
10,206.00
+23.98%
8,232.00
+2.87%
8,002.00
Capital Lease Obligations
125.00
-0.79%
126.00
-68.10%
395.00
+12.22%
352.00
Net Tangible Assets
-1,070.00
+46.58%
-2,003.00
-80.61%
-1,109.00
+11.21%
-1,249.00
Tangible Book Value
-1,070.00
+46.58%
-2,003.00
-80.61%
-1,109.00
+11.21%
-1,249.00
Current Provisions
—
177.00
-14.08%
206.00
-10.82%
231.00
Derivative Product Liabilities
—
—
—
0.00
Financial Assets
—
79.00
-26.17%
107.00
-28.19%
149.00
Foreign Currency Translation Adjustments
—
—
—
—
Minimum Pension Liabilities
—
—
—
—
Non Current Accrued Expenses
—
—
—
—
Other Inventories
-1.00
—
—
1.00
Preferred Shares Number
10.06
+0.00%
10.06
+0.00%
10.06
+0.00%
10.06
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
4,534.00
+31.99%
3,435.00
+37.24%
2,503.00
+64.02%
1,526.00
Cash Flow From Continuing Operating Activities
4,534.00
+32.03%
3,434.00
+37.09%
2,505.00
+64.05%
1,527.00
Net Income From Continuing Operations
2,892.00
+56.66%
1,846.00
+15.95%
1,592.00
+128.08%
698.00
Depreciation Amortization Depletion
1,368.00
+7.80%
1,269.00
+6.10%
1,196.00
+5.28%
1,136.00
Depreciation
471.00
+14.32%
412.00
+12.26%
367.00
+10.21%
333.00
Amortization Cash Flow
897.00
+4.79%
856.00
+3.38%
828.00
+3.11%
803.00
Depreciation And Amortization
1,368.00
+7.80%
1,269.00
+6.10%
1,196.00
+5.28%
1,136.00
Amortization Of Intangibles
897.00
+4.79%
856.00
+3.38%
828.00
+3.11%
803.00
Other Non Cash Items
192.00
+291.84%
49.00
-55.05%
109.00
-42.93%
191.00
Stock Based Compensation
299.00
+12.41%
266.00
+14.16%
233.00
+5.91%
220.00
Asset Impairment Charge
170.00
-62.88%
458.00
+438.82%
85.00
-35.61%
132.00
Deferred Tax
-2.00
+97.14%
-70.00
-6900.00%
-1.00
+98.41%
-63.00
Deferred Income Tax
-2.00
+97.14%
-70.00
-6900.00%
-1.00
+98.41%
-63.00
Operating Gains Losses
-139.00
-275.95%
79.00
+33.90%
59.00
-72.81%
217.00
Gain Loss On Investment Securities
-139.00
-275.95%
79.00
+33.90%
59.00
+5800.00%
1.00
Net Foreign Currency Exchange Gain Loss
—
—
—
—
Change In Working Capital
-246.00
+46.75%
-462.00
+40.00%
-770.00
+23.38%
-1,005.00
Change In Receivables
-269.00
+23.36%
-351.00
-47.48%
-238.00
-8.18%
-220.00
Changes In Account Receivables
-269.00
+23.36%
-351.00
-47.48%
-238.00
-8.18%
-220.00
Change In Inventory
-188.00
+17.54%
-228.00
+65.45%
-660.00
-105.61%
-321.00
Change In Payables And Accrued Expense
296.00
+21.81%
243.00
+105.93%
118.00
+146.27%
-255.00
Change In Payable
296.00
+21.81%
243.00
+105.93%
118.00
+146.27%
-255.00
Change In Account Payable
296.00
+21.81%
243.00
+105.93%
118.00
+146.27%
-255.00
Change In Other Current Assets
-85.00
+32.54%
-126.00
-1360.00%
10.00
+104.78%
-209.00
Investing Cash Flow
-2,640.00
+53.58%
-5,687.00
-120.94%
-2,574.00
-28.00%
-2,011.00
Cash Flow From Continuing Investing Activities
-2,639.00
+53.60%
-5,687.00
-120.94%
-2,574.00
-28.00%
-2,011.00
Net PPE Purchase And Sale
-876.00
-10.89%
-790.00
-11.11%
-711.00
-23.44%
-576.00
Purchase Of PPE
-876.00
-10.89%
-790.00
-11.11%
-711.00
-20.92%
-588.00
Sale Of PPE
—
3.00
-25.00%
4.00
-66.67%
12.00
Capital Expenditure
-1,130.00
-5.61%
-1,070.00
-33.75%
-800.00
-30.72%
-612.00
Net Investment Purchase And Sale
—
0.00
-100.00%
2.00
-96.43%
56.00
Purchase Of Investment
—
—
—
-24.00
Sale Of Investment
—
0.00
-100.00%
2.00
-96.43%
56.00
Net Business Purchase And Sale
-1,593.00
+65.67%
-4,640.00
-156.21%
-1,811.00
-17.83%
-1,537.00
Purchase Of Business
-1,593.00
+65.67%
-4,640.00
-156.21%
-1,811.00
-17.44%
-1,542.00
Gain Loss On Sale Of Business
—
0.00
0.00
-100.00%
22.00
Net Intangibles Purchase And Sale
-254.00
+9.29%
-280.00
-214.61%
-89.00
-293.48%
46.00
Purchase Of Intangibles
-254.00
+9.29%
-280.00
-214.61%
-89.00
-270.83%
-24.00
Net Other Investing Changes
83.00
+260.87%
23.00
-37.84%
37.00
—
Financing Cash Flow
-395.00
-121.78%
1,814.00
+36180.00%
5.00
+100.91%
-548.00
Cash Flow From Continuing Financing Activities
-395.00
-121.78%
1,814.00
+30133.33%
6.00
+101.10%
-547.00
Net Issuance Payments Of Debt
-491.00
-127.23%
1,803.00
+45175.00%
-4.00
+97.58%
-165.00
Issuance Of Debt
1,558.00
-33.19%
2,332.00
0.00
-100.00%
3,270.00
Repayment Of Debt
-2,049.00
-287.33%
-529.00
-13125.00%
-4.00
+99.88%
-3,435.00
Long Term Debt Issuance
1,558.00
-27.37%
2,145.00
0.00
-100.00%
3,270.00
Long Term Debt Payments
-258.00
-932.00%
-25.00
0.00
+100.00%
-3,184.00
Net Long Term Debt Issuance
1,300.00
-38.68%
2,120.00
0.00
-100.00%
86.00
Short Term Debt Issuance
—
187.00
0.00
0.00
Short Term Debt Payments
-1,791.00
-255.36%
-504.00
-12500.00%
-4.00
+98.41%
-251.00
Net Short Term Debt Issuance
-1,791.00
-464.98%
-317.00
-7825.00%
-4.00
+98.41%
-251.00
Net Common Stock Issuance
—
—
—
0.00
Common Stock Payments
—
—
—
0.00
Cash Dividends Paid
—
0.00
+100.00%
-28.00
+49.09%
-55.00
Repurchase Of Capital Stock
—
—
—
0.00
Proceeds From Stock Option Exercised
151.00
+5.59%
143.00
+13.49%
126.00
+51.81%
83.00
Net Other Financing Charges
-55.00
+58.33%
-132.00
-12.82%
-117.00
+71.53%
-411.00
Changes In Cash
1,499.00
+442.24%
-438.00
-553.73%
-67.00
+93.51%
-1,033.00
Effect Of Exchange Rate Changes
42.00
+481.82%
-11.00
-175.00%
-4.00
+55.56%
-9.00
Beginning Cash Position
606.00
-42.56%
1,055.00
-6.31%
1,126.00
-48.06%
2,168.00
End Cash Position
2,147.00
+254.29%
606.00
-42.56%
1,055.00
-6.31%
1,126.00
Free Cash Flow
3,404.00
+43.93%
2,365.00
+38.87%
1,703.00
+86.32%
914.00
Interest Paid Supplemental Data
319.00
+27.60%
250.00
-3.47%
259.00
-42.44%
450.00
Income Tax Paid Supplemental Data
561.00
-14.48%
656.00
+28.13%
512.00
-22.66%
662.00
Common Stock Issuance
—
—
—
0.00
Issuance Of Capital Stock
—
—
—
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Dividend Paid
—
0.00
+100.00%
-28.00
+49.09%
-55.00
Preferred Stock Issuance
—
—
—
0.00
Sale Of Business
—
0.00
0.00
-100.00%
5.00
Sale Of Intangibles
—
20.00
-33.33%
30.00
-57.14%
70.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category